Canada: subject, not period [Outliers]

posted by lechia – C of U, 2013-08-12 17:48 (3909 d 00:31 ago) – Posting: # 11263
Views: 10,105

❝ Likely. The Canadian guidance talks only about removal of outlying subjects, not observations.


How about semi- and fully-replicate studies? Would you still suggest removal of the subject or just the period in question? In some sense, in scaled BE studies the replicate serves as a self-contained re-dose study (which the FDA accepts and EMEA does not).

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,651 registered users;
118 visitors (1 registered, 117 guests [including 5 identified bots]).
Forum time: 18:19 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5